Answer:
Explanation:
Jan.1 2016 No entry
Dec.31 2016
Dr Compensation expense [$409,000/2] $204,500
Cr Paid in capital - Stock options $204,500
Dec. 31 2017
Dr Compensation expense [$409,000/2] $204,500
Cr Paid in capital - Stock options $204,500
Dec. 31 2018
Dr Cash [7440*$20] $148,800
Dr Paid in capital - Stock options [$409,000*(7440/9300)] $327,200
Cr Common stock [7440*$5] $37,200
Cr Paid in capital in excess of par [148,800+327,200-37,200] $438,800
Jan. 1 2020
Dr Paid in capital - Stock options [409,000-327,200] $81,800
Cr Paid in capital from expired stock $81,800